These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3079482)

  • 41. Stanford experience with chemotherapy for metastatic prostate cancer.
    Torti FM; Reese J; Freiha F
    Prog Clin Biol Res; 1990; 350():171-85. PubMed ID: 1696740
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chemotherapy of carcinoma of the endometrium. Current approaches].
    Sesti F; Mantenuto L; Silvestri C; Terenzi S; Viotto L; Piccione E
    G Ital Oncol; 1989; 9(2-3):59-62. PubMed ID: 2670761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.
    Richards B
    Prog Clin Biol Res; 1988; 269():177-86. PubMed ID: 2839846
    [No Abstract]   [Full Text] [Related]  

  • 44. New potential treatment modalities for disseminated prostatic cancer.
    Creaven PJ; Madajewicz S; Mittelman A
    Urol Clin North Am; 1984 May; 11(2):343-56. PubMed ID: 6203208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.
    Eisenberger MA; Simon R; O'Dwyer PJ; Wittes RE; Friedman MA
    J Clin Oncol; 1985 Jun; 3(6):827-41. PubMed ID: 2409240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment options for hormone-insensitive or independent prostatic carcinoma.
    Carroll PR; Narayan P
    Semin Urol; 1988 Nov; 6(4):322-35. PubMed ID: 3068770
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antineoplastic chemotherapies (including hormone therapy). Classification and mechanism of action].
    Clavel M
    Rev Prat; 1991 Dec; 41(26):2759-65. PubMed ID: 1808694
    [No Abstract]   [Full Text] [Related]  

  • 48. Update in cancer chemotherapy: genitourinary tract cancer, Part 3: Cancer of the prostate.
    Wright JC
    J Natl Med Assoc; 1988 Mar; 80(3):305-14. PubMed ID: 3280813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate cancer. Chemotherapy.
    Gibbons RP
    Cancer; 1987 Aug; 60(3 Suppl):586-8. PubMed ID: 3297287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is "off-protocol" chemotherapy for androgen-independent carcinoma of prostate warranted?
    Mani S; Vogelzang NJ
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):749-68. PubMed ID: 8773509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Does chemotherapy have a role in the treatment of prostatic cancer?].
    Verbaeys A
    Acta Urol Belg; 1991; 59(4):53-4. PubMed ID: 1819203
    [No Abstract]   [Full Text] [Related]  

  • 52. [The future of chemotherapy of prostatic cancer].
    Grillo-López AJ; Vélez-García E
    Bol Asoc Med P R; 1975 Nov; 67(11):327-30. PubMed ID: 1060454
    [No Abstract]   [Full Text] [Related]  

  • 53. [The contribution of hormone therapy (single or combined) to the prognosis of solid tumors].
    Longueville J
    Rev Med Liege; 1984 Feb; 39(3):108-10. PubMed ID: 6718862
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapy as science. Remarks on the problem of the comparative evaluation of therapy exemplified by cytostatics].
    Begemann H
    Dtsch Med Wochenschr; 1988 Jul; 113(30):1198-203. PubMed ID: 3293963
    [No Abstract]   [Full Text] [Related]  

  • 55. Controlled studies in clinical cancer research.
    Chalmers TC; Block JB; Lee S
    N Engl J Med; 1972 Jul; 287(2):75-8. PubMed ID: 4555591
    [No Abstract]   [Full Text] [Related]  

  • 56. Chemotherapy for prostate cancer.
    Wang J; Waxman J
    Clin Oncol (R Coll Radiol); 2001; 13(6):453-4. PubMed ID: 11824885
    [No Abstract]   [Full Text] [Related]  

  • 57. Rationale for chemotherapeutic approaches to prostate cancer.
    Creaven PJ
    Prostate; 1984; 5(1):63-74. PubMed ID: 6364077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medical management of prostatic cancer: some current questions.
    Smith PH
    Eur Urol; 1980; 6(2):65-8. PubMed ID: 6987062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of the karyopyknotic index in the course control of hormone-treated prostatic carcinoma].
    Funke PJ; Chiari R
    Z Urol Nephrol; 1976 Jul; 69(7):501-5. PubMed ID: 998016
    [No Abstract]   [Full Text] [Related]  

  • 60. [Analysis of dissertations on antineoplastic chemotherapy presented 1981-1985].
    Moroz LV; Syrkin AB; Strelkova RM
    Vopr Onkol; 1988; 34(7):786-92. PubMed ID: 3047975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.